IFS Advisors’s Dare Bioscience DARE Stock Holding History

IFS Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.73K	Hold	950	–	–	﹤0.01%	185
2025 Q4	$1.83K	Hold	950	–	–	﹤0.01%	158
2025 Q3	$2K	Hold	950	–	–	﹤0.01%	148
2025 Q2	$2.27K	Hold	950	–	–	﹤0.01%	138
2025 Q1	$2.75K	Hold	950	–	–	﹤0.01%	151
2024 Q4	$2.96K	Hold	950	–	–	﹤0.01%	134
2024 Q3	$3.08K	Hold	950	–	–	﹤0.01%	110
2024 Q2	$3.83K	Hold	950	–	–	﹤0.01%	98
2024 Q1	$5.59K	Hold	950	–	–	﹤0.01%	87
2023 Q4	$3.52K	Hold	950	–	–	﹤0.01%	92
2023 Q3	$5.26K	Hold	950	–	–	0.01%	79
2023 Q2	$10.4K	Hold	950	–	–	0.03%	59
2023 Q1	$11.9K	Hold	950	–	–	0.05%	45
2022 Q4	$9.46K	Hold	950	–	–	0.02%	57
2022 Q3	$11K	Hold	950	–	–	0.02%	44
2022 Q2	$14K	Hold	950	–	–	0.04%	39
2022 Q1	$16K	Hold	950	–	–	0.02%	43
2021 Q4	$22K	Hold	950	–	–	0.02%	50
2021 Q3	$19K	Hold	950	–	–	0.01%	27
2021 Q2	$21K	Buy	+950	New	+$16.2K	0.01%	28

Other funds holding DARE

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IFS Advisors's DARE Position: Q1 2026 in Review

IFS Advisors held its Dare Bioscience (DARE) position steady in Q1 2026 at 950 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

IFS Advisors first reported a position in DARE in Q2 2021 and has held it in 20 quarters since. The position peaked at $22K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

IFS Advisors held 950 shares of Dare Bioscience worth $1.73K as of Q1 2026.
IFS Advisors left its Dare Bioscience share count unchanged in Q1 2026.
Dare Bioscience made up ﹤0.01% of IFS Advisors's portfolio in Q1 2026, its #185 holding.
IFS Advisors first reported a position in Dare Bioscience in Q2 2021 and has held it in 20 quarters since.
IFS Advisors's Dare Bioscience position peaked at $22K in Q4 2021.
25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on IFS Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.